ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Aurora, CO, USA:

Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer

This study seeks to determine the effectiveness of Rucaparib as maintenance therapy for metastatic and recurrent endometrial cancer...

Active, not recruiting
Metastatic Endometrial Cancer
Drug: Rucaparib
Drug: Placebo Oral Tablet

Phase 2

University of Colorado Denver (CU Denver)
University of Colorado Denver (CU Denver)

Aurora, Colorado, United States

Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...

Active, not recruiting
Endometrial Cancer
Lung Cancer
Drug: Pembrolizumab
Drug: RGX-104

Phase 1

Inspirna

Aurora, Colorado, United States and 20 other locations

IMGN151-1001 is a Phase 1, first in human, open-label dose-escalation and expansion study in adult patients with recurrent endometrial cancer...

Enrolling
Endometrial Cancer
Fallopian Tube Cancer
Drug: IMGN151

Phase 1

ImmunoGen
ImmunoGen

Aurora, Colorado, United States and 8 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Aurora, Colorado, United States and 202 other locations

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...

Enrolling
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Endometrial Cancer
Biological: vudalimab

Phase 2

Xencor
Xencor

Aurora, Colorado, United States and 16 other locations

Phase.* Cohort A: Advanced or Metastatic Triple Negative Breast Cancer (TNBC) (IO-treated)* Cohort B: Advanced or Metastatic Triple Negative ...

Active, not recruiting
Endometrial Cancer
Solid Tumor, Unspecified, Adult
Drug: Fruquintinib
Drug: Tislelizumab

Phase 1, Phase 2

HUTCHMED
HUTCHMED

Aurora, Colorado, United States and 15 other locations

in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...

Enrolling
Endometrial Adenocarcinoma
Platinum-resistant Ovarian Cancer
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Aurora, Colorado, United States and 67 other locations

will also assess the clinical benefit of combination therapy in participants with advanced unresectable and/or metastatic ICI refractory solid tumors...

Enrolling
Esophageal Cancer
Colo-rectal Cancer
Drug: NC410
Drug: pembrolizumab

Phase 1, Phase 2

NextCure

Aurora, Colorado, United States and 16 other locations

preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected in Dose Es...

Enrolling
Solid Tumor
Ovarian Neoplasms
Drug: NKT3447

Phase 1

NiKang Therapeutics

Denver, Colorado, United States and 7 other locations

) antibody (balstilimab), and to assess the maximum tolerated dose (MTD) in participants with advanced solid tumors. This study will also de...

Enrolling
Endometrial Cancer
Advanced Cancer
Drug: Balstilimab
Drug: Botensilimab

Phase 1

Agenus
Agenus

Aurora, Colorado, United States and 18 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems